Skip to main content

Extra Vaccine Halts Mumps Outbreak

A third dose of the MMR vaccine given during an intense outbreak appears to have provided herd-immunity to control the spread of the disease.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

A transmission electron micrograph of mumps virionsWikimedia, Centers for Disease Control and PreventionGiving previously vaccinated children an additional dose of the measles, mumps, and rubella (MMR) vaccine helped to control an intense outbreak in a small, tight-knit religious community, according to researchers from the Centers for Disease Control and Prevention. The new study, published this week (November 5) in Pediatrics, suggests that the intervention provided a herd-immunity effect—where a significant part of a population with immunity to a particular pathogen acts as a firewall to protect the entire community by disrupting the chain of infection.

The researchers studied a mumps outbreak in an orthodox Jewish community in Orange County, New York, in late 2009 in which 400 children from three schools fell ill. Most of the children in the community had been vaccinated with the recommended 2 doses but a combination of large families and crowded schools overwhelmed that protection, the researchers say.

So a third vaccine was administered to children with no history of mumps in the outbreak. Shortly after this intervention, the number of new cases fell across all age groups by 19.6 percent. And they dropped even more dramatically—by 96 percent—in students aged 11 to 17, a group that had experienced more intense transmission.

This decline shortly after intervention suggests that a third dose of MMR vaccine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni
Conceptual multicolored image of DNA helices.

Exploring the Most Impactful CRISPR Stories

Promega

Products

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform

Beckman Coulter Life Sciences Logo

Beckman Coulter Life Sciences Launches Vi-CELL BLU 2.0 Software to Advance Data Integrity and GMP Readiness in Cell Analysis